🔗 Permalink

Inventor profile of:

Peter M. Lauer

City:

Albany, California

Country:

United States

Published Applications:

Last publication date:

2018-10-04

Top Assignees for applications by Peter M. Lauer

The entities that hold a legal rights for patent applications filed by inventor Lauer Peter M.:

ADURO BIOTECH, INC. 10 BERKELEY, CA United States
ADURO BIOTECH 6 Berkeley, CA United States
Providence Health & Services—Oregon 2 Portland, OR United States
PROVIDENCE HEALTH & SERVICES-OREGON D/B/A PROVIDEN CE PORTLAND MEDICAL CENTER 1 Portland, OR United States
THE JOHNS HOPKINS UNIVERSITY 1 Baltimore, MD United States
Providence Health & Services - Oregon d/b/a Providence Portland Medical Center 1 Portland, OR United States
ANZA THERAPEUTICS, INC. 1 Concord, CA United States

Recent patent applications by Lauer Peter M.

Peter M. Lauer from Albany, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-10-04

US20180280489A1

Human necessities

ENGINEERED LISTERIA AND METHODS OF USE THEREOF

#2 | 2018-03-29

US20180085446A1

Human necessities

Immunogenic Fusion Proteins For The Treatment Of Cancer

#3 | 2018-02-01

US20180030457A1

Chemistry; metallurgy

Protein expression enhancer sequences and use thereof

#4 | 2018-01-25

US20180021420A1

Human necessities

METHODS AND COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE TO EGFRVIII

#5 | 2018-01-04

US20180000917A1

Human necessities

ENGINEERED LISTERIA AND METHODS OF USE THEREOF

#6 | 2017-09-07

US20170253637A1

Chemistry; metallurgy

SIGNAL PEPTIDE FUSION PARTNERS FACILITATING LISTERIAL EXPRESSION OF ANTIGENIC SEQUENCES AND METHODS OF PREPARATION AND USE THEREOF

#7 | 2017-03-23

US20170081673A1

Chemistry; metallurgy

FACULTATIVELY ATTENUATED BACTERIAL SPECIES AND METHODS OF PREPARATION AND USE THEREOF

#8 | 2016-12-01

US20160346369A1

Human necessities

Epidermal growth factor receptor variant III-mesothelin fusions and methods of using the same

#9 | 2016-11-10

US20160324945A1

Human necessities

Immunogenic fusion proteins for the treatment of cancer

#10 | 2016-03-17

US20160074491A1

Human necessities

Methods and compositions for inducing an immune response to EGFRvIII

#11 | 2014-10-23

US20140315314A1

Human necessities

Engineered and methods of use thereof

#12 | 2014-07-03

US20140186387A1

Chemistry; metallurgy

Signal peptide fusion partners facilitating listerial expression of antigenic sequences and methods of preparation and use thereof

#13 | 2014-05-08

US20140127816A1

Chemistry; metallurgy

Facultatively attenuated bacterial species and methods of preparation and use thereof

#14 | 2014-02-06

US20140037662A1

Chemistry; metallurgy

Methods and compositions for inducing an immune response to EGFRvIII

#15 | 2013-12-05

US20130323275A1

Human necessities

METHODS AND COMPOSITIONS FOR INDUCING A T-CELL RESPONSE TO PLASMODIUM SPECIES

#16 | 2012-05-17

US20120121643A1

Chemistry; metallurgy

Engineered listeria and methods of use thereof

#17 | 2012-04-26

US20120100170A1

Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEPATITIS C

#18 | 2011-11-24

US20110287055A1

Chemistry; metallurgy

COMPOSITIONS COMPRISING PRFA* MUTANT LISTERIA AND MEHTODS OF USE THEREOF

#19 | 2011-10-06

US20110245480A1

Human necessities

Engineered Listeria and methods of use thereof

#20 | 2010-05-27

US20100129406A1

Human necessities

HOLIN-ENHANCED VACCINES AND REAGENTS, AND METHODS OF USE THEREOF

InventorID:

557333 ⎘